about
Use of Sodium Bicarbonate in Cardiac Arrest: Current Guidelines and Literature ReviewHypomagnesemia in Critically Ill Sepsis PatientsThe Use of Sodium Bicarbonate in the Treatment of Acidosis in Sepsis: A Literature Update on a Long Term DebatePharmacokinetic Changes and Dosing Modification of Aminoglycosides in Critically Ill Obese Patients: A Literature ReviewDifferential diagnosis and treatment of acute cauda equina syndrome in the human immunodeficiency virus positive patient: a case report and review of the literature.Acute respiratory distress syndrome: pathophysiology and therapeutic optionsLong QT Syndrome Leading to Multiple Cardiac Arrests After Posaconazole Administration in an Immune-Compromised Patient with Sepsis: An Unusual Case ReportChronotypology and melatonin alterations in minimal hepatic encephalopathy.Sepsis requiring intensive care following intramuscular injections: two case reports.Pancreatic mediastinal pseudocyst presenting as a posterior mediastinal mass with recurrent pleural effusions: a case report and review of the literatureCarbapenemase-producing Klebsiella pneumoniae bloodstream infection in critically ill patients: risk factors and predictors of mortality.Suppurative necrotizing granulomatous lymphadenitis in adult-onset Still's disease: a case report.Prolonged high-dose intravenous magnesium therapy for severe tetanus in the intensive care unit: a case series.-572 G/C single nucleotide polymorphism of interleukin-6 and sepsis predisposition in chronic renal disease.The Role of Procalcitonin in the Diagnosis of Meningitis: A Literature Review.Simultaneous Bilateral Spontaneous Pneumothorax in an Adult Patient With Pulmonary Langerhans Cell Histiocytosis: A Case ReportPeripheral Inserted Central Catheter Use and Related Infections in Clinical Practice: A Literature UpdateRisk factors for acute kidney injury in critically ill patients with bacteraemia by carbapenem non-susceptible Gram negative bacteriaThe utility of brain natriuretic peptides in septic shock as markers for mortality and cardiac dysfunction: A systematic reviewMolecular characteristics and predictors of mortality among Gram-positive bacteria isolated from bloodstream infections in critically ill patients during a 5-year period (2012-2016)Triple combination therapy with high-dose ampicillin/sulbactam, high-dose tigecycline and colistin in the treatment of ventilator-associated pneumonia caused by pan-drug resistant Acinetobacter baumannii: a case series studyThe use of soluble urokinase plasminogen activator receptor (suPAR) as a marker of sepsis in the emergency department setting. A current reviewBreakthrough bloodstream infections in critically ill non-neutropenic patients: higher incidence and better survival than non-breakthrough infections
P50
Q26764902-110AA749-86C4-4CA2-ADE5-8B2BE91FCAD7Q26777236-1527BC7D-1713-459D-ACE8-ECC8A0F5280FQ26796142-AD0640B0-4FDE-435E-A05F-CDBCB7C9FD43Q29248398-936AE9CB-0BAB-4827-89D8-3C8C2F68CFB1Q31105981-8B8FC66E-5ED9-4F37-A9E0-503CD0E8699CQ35757010-9F132C2A-0BB3-4692-A738-2266819A7DC9Q37020761-1AD0E4B8-008B-4795-97FC-9F87C5E69BD8Q37224939-D98A086B-62B7-45BD-BFE4-0050A76C9569Q37403459-2A249D70-0897-41CE-9840-9C6480BA2BCAQ38473232-6517798E-B80A-4622-AFA3-52D02CE7E40FQ39012881-1E96F8B2-7EB8-4AF2-ACBD-72EF4060C2D6Q40270983-30CBA3EB-DB84-4E60-803C-2D7B35180F63Q40277768-CA47B5E0-9CB3-4428-9782-4831DBB7FF8CQ40954376-33A221A2-8305-43F8-8AED-F1A546141C0AQ55483351-A5B47EB9-16C1-4D74-AF82-C71D638B1367Q58799490-026A6070-E23D-4DE1-8C6D-4F5F47E027DCQ64080607-D21B14A6-F8C7-414D-B610-EC28485A08F1Q92047309-81B913BD-A267-443B-94C3-99A96B000CD3Q92182418-0A4B9925-7FE9-428C-8565-2DA36C9C14DCQ92394742-5162CC06-F2A7-48BD-8BA9-BA0EAE42B2E9Q92435925-232F6B9A-3F09-499B-A69B-D1853923E7A4Q92754952-4598D358-E603-4671-8555-E18C47B4D369Q92768446-09FE05F7-C7FA-4448-BC73-18B3B099913B
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
V Karamouzos
@ast
V Karamouzos
@en
V Karamouzos
@es
V Karamouzos
@nl
type
label
V Karamouzos
@ast
V Karamouzos
@en
V Karamouzos
@es
V Karamouzos
@nl
prefLabel
V Karamouzos
@ast
V Karamouzos
@en
V Karamouzos
@es
V Karamouzos
@nl
P106
P1153
26867788200
P31
P496
0000-0003-1122-4213